Eton Pharmaceuticals Inc.
Organization details
- Legal name
- Eton Pharmaceuticals Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Deer Park
- Headquarters state / province
- Illinois
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- ETON
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001710340
- EIN
- 37-1858472
Board of directors
-
Charles J. Casamento · DirectorSince 2023
-
Jennifer McKie Adams · DirectorSince 2023
-
Norbert G. Riedel · DirectorSince 2023
-
Paul Maier V · DirectorSince 2023
-
Sean Brynjelsen · Director · President & CEOSince 2023
Chief executives
Director election results
Annual meeting of June 9, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
64.0%
-
86.2%
Board connections
2 of this board's directors also sit on 4 other boards. 3 are in the same sector.
-
GT Biopharma Inc. Same sectorvia Charles J. Casamento
- via Charles J. Casamento
-
Jazz Pharmaceuticals plc Same sectorvia Norbert G. Riedel
-
Relmada Therapeutics Inc. Same sectorvia Charles J. Casamento
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $30,753,955
- 29 sales by 6 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 10, 2026 | Charles J. Casamento Director | Option exercise | +12,500 | $7.31 | $91,375 |
| Nov 10, 2026 | Charles J. Casamento Director | Option exercise | +27,400 | $3.58 | $98,092 |
| Nov 10, 2026 | Charles J. Casamento Director | Option exercise | +19,655 | $8.61 | $169,230 |
| Nov 10, 2026 | Charles J. Casamento Director | Option exercise | +21,000 | $3.78 | $79,380 |
| Nov 10, 2026 | Charles J. Casamento Director | Open-market sale | −6,380 | $64.33 | $410,417 |
| Nov 10, 2026 | Charles J. Casamento Director | Open-market sale | −14,715 | $65.32 | $961,256 |
| Nov 10, 2026 | Charles J. Casamento Director | Open-market sale | −22,601 | $66.26 | $1,497,576 |
| Nov 10, 2026 | Charles J. Casamento Director | Open-market sale | −33,956 | $67.11 | $2,278,797 |
| Nov 10, 2026 | Charles J. Casamento Director | Open-market sale | −2,903 | $67.87 | $197,025 |
| Oct 6, 2026 | Krempa David Officer (Chief Business Officer) | Open-market sale | −4,166 | $55.07 | $229,406 |
| Oct 2, 2026 | Krempa David Officer (Chief Business Officer) | Option exercise | +10,522 | — | — |
| Aug 28, 2026 | Paul Maier V Director | Option exercise | +50,000 | $3.78 | $189,000 |
| Aug 28, 2026 | Paul Maier V Director | Open-market sale | −36,387 | $58.64 | $2,133,734 |
| Aug 28, 2026 | Paul Maier V Director | Open-market sale | −13,485 | $60.21 | $811,932 |
| Aug 28, 2026 | Paul Maier V Director | Open-market sale | −128 | $61.77 | $7,907 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Eton Pharmaceuticals Inc.
Who is the CEO of Eton Pharmaceuticals Inc.?
Sean Brynjelsen is Eton Pharmaceuticals Inc.'s President & CEO.
How many directors are on Eton Pharmaceuticals Inc.'s board?
Eton Pharmaceuticals Inc.'s board has 5 directors: Charles J. Casamento, Jennifer McKie Adams, Norbert G. Riedel, Paul Maier V and Sean Brynjelsen.
Are Eton Pharmaceuticals Inc. insiders buying or selling shares?
Over the last 12 months, Eton Pharmaceuticals Inc. insiders made no open-market purchases and sold $30.8 million of shares in 29 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="eton-pharmaceuticals-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.